Innovation for Health - 14 February 2019
Global Investor Forum Contact
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare

Research Scientist Novel T Cell Therapies


For our Amsterdam based research facility, Kite Pharma EU B.V., we are seeking a highly motivated Research Scientist with expertise and a track record in T cell engineering/T cell immunology to join our dynamic and ambitious team. You will assume a key scientific role by contributing to the design and execution of our scientific projects. The successful candidate will manage a small scientific team and actively engage in experimental work. The Research Scientist will plan and execute laboratory studies, organize and analyze results and communicate and present findings in team meetings.

Responsibilities include, but are not limited to:

  • Designing laboratory experiments to develop novel approaches to target cancer with engineered T cells. Examples include, but are not limited to, strategies to efficiently identify neo-antigen reactive T cells, the identification and non-clinical evaluation of therapeutic TCR candidates and the in vitro and in vivo assessment of engineering strategies to enhance the therapeutic potency of TCR-modified T cells
  • Supervise the work of a small research team including but not limited to organizing and prioritizing laboratory work according to timelines and review of generated experimental results;
  • Hands-on execution of laboratory work alongside the team;
  • Analyze and present scientific results to diverse audiences;
  • Document experimental results to enable clinical studies and patent applications;
  • Work with cross-functional international teams to advance the development of T cell therapies including those targeting tumor neo-antigens
  • Other duties as assigned


  • Ph.D. degree with subsequent postdoctoral training or industry experience in T cell engineering/T cell immunology
  • Evidence of a successful academic or industry track-record (for example lead authorships on publications and/or being a named inventor on patent applications).
  • Further expertise in one or multiple of the following areas is highly advantageous: tumor neo-antigen biology, CD4+ T cell immunobiology, genetic screenings, e.g. using CRISPR and RNAi, next-generation single cell PCR methods (e.g. Droplet-based PCR methods), in vivo models to study T cell immunity and process development to detect and isolate antigen-specific T cells
  • Familiarity with immunological techniques applied to study T cell biology and develop T cell therapies, including but not limited to isolation, in vitro cultivation and phenotypic characterization of primary human immune cells, genetic manipulation of primary immune cells and cell lines using various transduction systems and multi-color flow cytometry
  • Ability to translate scientific ideas into comprehensive experiments aiming to develop broadly applicable, industrial-scale T cell therapies
  • Strong organizational and record keeping skills
  • Proactive, self-motivated team player with strong interpersonal skills, appropriate sense of urgency and the ability to work independently
  • Excellent interpersonal, verbal and written communication skills are essential in this collaborative work environment
  • Comfortable in a fast-paced growing company environment with minimal direction and able to adjust workload based upon changing priorities

More information?

Would you like to know more before you apply? Please contact Heidi Kroon - Talent Acquisition Specialist, via:




Kite Pharma B.V.

Publication date


Publication end date


Kite Pharma B.V.
Vacature delen via:
Join the VIP CEO-Investor dinner

Are you a CEO or an investor and interested to network with high level delegates during our special VIP CEO-Investor evening programme and dinner? Book your tickets now!  Register here

Join the VIP CEO-Investor dinner!
Programme overview now online!

The (provisional) programme of Innovation for Health 2019 is now online! Are you as excited as we are about the themes, sessions and speakers of this years' edition?
Check this years' programme

Programme overview 2019
Selected start-up pitches

An exciting part of the programme is the yearly start-up pitch contest. Ten start-up companies will get the opportunity to pitch their company and healthcare innovation to key players and decision makers in Health & Life sciences sector on 14 February at Innovation for Health and Global Investor Forum! Find out who is selected to compete in the yearly start-up pitch contest!
Check it here!

Join the Design Expo!
Sponsors & Partners
Main partner
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Janssen Diagnostics - Janssen
Gold sponsor
Medical Delta
Silver sponsor
NLC The Healthtec Venture Builder
Award sponsor
AXON Lawyers
Award sponsor
Vereniging Innovatieve Geneesmiddelen
Global Investor Forum
© 2018 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.